Castle Biosciences Inc
NASDAQ:CSTL
Relative Value
The Relative Value of one
CSTL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 32.4 USD,
Castle Biosciences Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CSTL Competitors Multiples
Castle Biosciences Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
944.8m USD | 2.7 | -77.1 | 85.2 | -19.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD | 0.3 | 212.6 | 14 | 14 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.2B USD | 0.3 | 12.7 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR | 0.3 | 12.2 | 7.8 | 9.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR | 1.2 | 24.3 | 10.6 | 16.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR | 1.2 | 33.1 | 10.4 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD | 1.7 | 26.9 | 14.4 | 20.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD | 2 | 22.4 | 12.2 | 16.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 16.2 | 6.4 | 13.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD | 14.1 | -31.8 | -33.6 | -30.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 12.9 | 7.3 | 10 |